Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Activated microglial phenotypes in the hippocampal CA2 subfield are implicated in Lewy body disease progression.
Journal: Acta neuropathologica
Published: February 26, 2026
Microglial reactivity in the hippocampal CA2 is associated with advanced neuronal α-synucleinopathy.
Microglial reactivity in the hippocampal CA2 is associated with advanced neuronal α-synucleinopathy.
Journal: bioRxiv : the preprint server for biology
Published: February 23, 2026
Quantitative systems pharmacology modeling sheds light into the dose response relationship of a trispecific T cell engager in multiple myeloma.
Journal: Scientific reports
Published: September 21, 2021
α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson's disease.
Journal: JCI insight
Published: December 11, 2019
TRIM11 Prevents and Reverses Protein Aggregation and Rescues a Mouse Model of Parkinson's Disease.
Journal: Cell reports
Published: October 07, 2019
Differential α-synuclein expression contributes to selective vulnerability of hippocampal neuron subpopulations to fibril-induced toxicity.
Journal: Acta neuropathologica
Published: September 26, 2017
HE3286 reduces axonal loss and preserves retinal ganglion cell function in experimental optic neuritis.
Journal: Investigative ophthalmology & visual science
Published: August 21, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026